Federal grants to The Winifred Masterson Burke Medical Research Institute, Inc
The Winifred Masterson Burke Medical Research Institute, Inc in White Plains, New York received $61.8 million in federal grants from fiscal 2021 to 2025, across 26 awards. Its largest program was Aging Research, with $35.9 million. In fiscal 2025 it was awarded $14.9 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$61.8 million
- Awards26
- Awarded in FY 2025$14.9 million
- Largest award$30.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 14 | $6.9 million |
| FY 2022 | 14 | $16.1 million |
| FY 2023 | 13 | $16.7 million |
| FY 2024 | 12 | $7.1 million |
| FY 2025 | 11 | $14.9 million |
Programs that fund The Winifred Masterson Burke Medical Research Institute, Inc
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 3 | $35.9 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 16 | $19.9 million |
| Child Health and Human Development Extramural Research | 2 | $3.3 million |
| Vision Research | 1 | $1.5 million |
| Trans-NIH Research Support | 2 | $656,420 |
| Research Infrastructure Programs | 1 | $272,744 |
| Oral Diseases and Disorders Research | 1 | $248,999 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 26 | $61.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Phase II randomized controlled trial of benfotiamine in early alzheimer's disease - we propose a seamless phase 2A-2B trial investigating benfotiamine, a prodrug of thiamine, as a first-in- class small molecule treatment for early alzheimer's disease (AD). We call this proposed trial `benfotiamine i | Aging Research | July 7, 2022 | $30.3 million |
| Electrophysiological evaluation of brain regions vulnerable to alzheimers disease | Aging Research | April 5, 2021 | $3.6 million |
| Corticospinal neuron dysfunction and degeneration in als: testing the role of corticomotor connectivity in motor neuron disease - abstract (summary): in patients with amyotrophic lateral sclerosis (ALS) and the related motor neuron disease (MND) primary lateral sclerosis (PLS), deficits in motor con | Extramural Research Programs in the Neurosciences and Neurological Disorders | November 24, 2020 | $3.4 million |
| Neural predictors of hand therapy efficacy in children with cerebral palsy | Child Health and Human Development Extramural Research | August 1, 2021 | $2.6 million |
| Dissecting spinal interneuron circuits to control skilled movements | Extramural Research Programs in the Neurosciences and Neurological Disorders | February 23, 2021 | $2.3 million |
| Mechanistic links between the benefits of pharmacologically high thiamine (vitamin B1) in alzheimer's disease to advanced glycation endproducts (AGE) - experimental data linking thiamine (vitamin B1) deficiency to alzheimer’s disease (AD) inspired our clinical trial, which generated preliminary evid | Aging Research | January 31, 2024 | $2.2 million |
| Synapse elimination in the central nervous system | Extramural Research Programs in the Neurosciences and Neurological Disorders | June 18, 2021 | $2.2 million |
| Studying the molecular regulation of mge projection neuron identity by ST18 - project summary: the medial ganglionic eminence (MGE) is a neural progenitor domain located in the ventral telencephalon. It is well-studied for its production of cortical interneurons, a broadly distributed population of | Extramural Research Programs in the Neurosciences and Neurological Disorders | February 18, 2021 | $2.0 million |
| Immune-mediated mechanisms underlying conditioning-induced stroke recovery | Extramural Research Programs in the Neurosciences and Neurological Disorders | February 10, 2021 | $1.7 million |
| Transcriptional regulation over neurogenesis of cortical output neuron segmental identity and diversity - subcerebral projection neurons (SCPN) reside in the neocortex, and extend axons to subcerebral targets in the brainstem and spinal cord. Corticospinal neurons (CSN), a subclass of scpn, project | Extramural Research Programs in the Neurosciences and Neurological Disorders | February 20, 2023 | $1.5 million |
Questions people ask
How much federal grant money does The Winifred Masterson Burke Medical Research Institute, Inc get?
$61.8 million in 26 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives The Winifred Masterson Burke Medical Research Institute, Inc the most?
The Department of Health and Human Services, with $61.8 million in 26 awards.
What is The Winifred Masterson Burke Medical Research Institute, Inc's largest federal grant?
$30.3 million under Aging Research, with its first action in the period on July 7, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund The Winifred Masterson Burke Medical Research Institute, Inc?
Its largest are Aging Research, Extramural Research Programs in the Neurosciences and Neurological Disorders and Child Health and Human Development Extramural Research.
Other grant recipients in White Plains
- County of Westchester
- Power Authority of State of New York
- Westchester, County of
- Westchester Jewish Community Services, Inc.
- White Plains Housing Authority
- Oligomerix Inc
- City of White Plains
- My Sisters' Place, Inc.
Largest federal grant recipients in New York · Federal grants in New York